2021 West Oncology Conference

Posted by & filed under Uncategorized.

The 6th Annual West Oncology Conference will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, hematological malignancies, and lung cancer in a practical and interactive format, fostering discussion… Read more »

Dr. Lee Schwartzberg on HER2– HR+ Breast Cancer: Tesetaxel & Capecitabine

Posted by & filed under Uncategorized.

Lee S. Schwartzberg, MD, of the West Cancer Center, discusses phase III results from the CONTESSA study, which showed that an all-oral regimen of tesetaxel plus a reduced dose of capecitabine significantly improved progression-free survival compared with capecitabine alone in patients with HER2-negative, hormone receptor–positive metastatic breast cancer previously treated with a taxane (Abstract GS4-01)…. Read more »

Dr. Gregory Vidal Discusses Use of Patient Registries in Neratinib Study

Posted by & filed under Uncategorized.

Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer.   Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »

OneR and West Cancer Physicians Give Ten Presentations at SABCS

Posted by & filed under Uncategorized.

OneR and West Cancer Physicians Give Ten Presentations at SABCS   OneOncology, the national network of independent oncology practices, announced today that physicians from OneR, the OneOncology Research Network and West Cancer and Research Institute will share results from ten research studies at the San Antonio Breast Cancer Symposium® (SABCS®), an international gathering of physicians and… Read more »

X